CSL Ozempic impact: Biotech giant says business shielded from big hits

  • 📰 FinancialReview
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 90%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

The biotech giant also outlined an inverse Uber-style surge fee to reward people donating blood outside peak hours.

On Monday it outlined why it thinks its business is largely shielded.Biotechnology giant CSL argues an ageing population will help shield its business from any falloutweight loss, and potentially undermining its investment in therapies targeting kidney disease.

The plans were outlined at an investor day for CSL, a $116 billion company that is one of Australia’s big biotechnology growth stories, evolving from a government-owned enterprise established in 1916 to having 30,000 staff delivering products in more than 100 countries.with margins in blood collection centres under pressure and rivals planning to launch generic drugs against its iron deficiency product, Ferinject.

CSL head of research and development Bill Mezzanotte maintained the patients in the trial only represented a “small percentage of the overall dialysis patient population, which of course is only a small percentage of the business”. “However, offset by that, GLP-1s will do nothing for ageing,” he said. “And the overall population remains to continue to age, and that will likely balance the effect and keep the number of in total, relatively constant.”

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 2. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Our biggest healthcare company says it isn’t scared of OzempicCSL has outlined its growth strategy to investors and played down concerns about weight-loss drugs’ impact on some of its key products.
ソース: theage - 🏆 8. / 77 続きを読む »

Our biggest healthcare company says it isn’t scared of OzempicCSL has outlined its growth strategy to investors and played down concerns about weight-loss drugs’ impact on some of its key products.
ソース: brisbanetimes - 🏆 13. / 67 続きを読む »